MetaCap

Capstone (CAPS) vs PMGC (ELAB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Capstone is the larger company by market cap ($1.3 million vs $1.3 million), about 1.0 times the size. Capstone converts more of its revenue into profit, with a net margin of -45.3% versus -1313.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CAPS+927.84%ELAB-63.69%
+2019%+928%-163%
Oct 7, 20261 yearNov 20, 2026
CAPS+949.56%ELAB-62.99%
+1880%+862%-156%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CAPS versus ELAB key metrics
MetricCAPSELAB
Share price$1.44$1.14
Market cap$1.35M$1.33M
1-day change-9.15%-10.24%
EPS (TTM)$-89.68$-555.60
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$46.88M$590.08K
Revenue growth (YoY)+4.47%—
Net income (latest FY)$-21.23M$-7.75M
Gross margin23.02%31.40%
Operating margin-23.43%—
Net margin-45.28%-1313.00%
52-week high$28.50$1,344.00
52-week low$1.42$1.14
Distance from 52-week high-94.95%-99.92%
Analyst consensusnone—
Avg. price target upside+108.33%—
Average volume153.70K279.01K
Shares outstanding935.38K1.17M
Employees9332
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Capstone is more profitable, keeping -45.3 cents of every revenue dollar as net income versus -1313.0 cents for PMGC.

About Capstone

CAPS stock →

Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.

Health Care · Biotechnology: Pharmaceutical Preparations · 93 employees

About PMGC

ELAB stock →

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.

Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees

CAPS vs ELAB FAQ

Which is bigger, Capstone or PMGC?

Capstone (CAPS) is larger, with a market capitalization of $1.35M compared with $1.33M for PMGC (ELAB).

Are Capstone and PMGC in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons